Cargando…
Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method
PURPOSE: Whether neoadjuvant chemotherapy (NCT) followed by concurrent chemoradiotherapy (CCRT) could improve survival in nasopharyngeal carcinoma (NPC) remains controversial especially in the era of intensity-modulated radiation therapy (IMRT), and we explored the role of NCT for NPC patients. PATI...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476787/ https://www.ncbi.nlm.nih.gov/pubmed/28652773 http://dx.doi.org/10.2147/OTT.S135590 |
_version_ | 1783244665076580352 |
---|---|
author | Chen, Xueling Zhu, Xiaodong Liang, Zhongguo Li, Ling Qu, Song Chen, Kaihua Pan, Xinbin |
author_facet | Chen, Xueling Zhu, Xiaodong Liang, Zhongguo Li, Ling Qu, Song Chen, Kaihua Pan, Xinbin |
author_sort | Chen, Xueling |
collection | PubMed |
description | PURPOSE: Whether neoadjuvant chemotherapy (NCT) followed by concurrent chemoradiotherapy (CCRT) could improve survival in nasopharyngeal carcinoma (NPC) remains controversial especially in the era of intensity-modulated radiation therapy (IMRT), and we explored the role of NCT for NPC patients. PATIENTS AND METHODS: A retrospective review was conducted of 255 NPC patients treated with NCT+CCRT (n=67) or CCRT alone (n=188) based on IMRT between December 2006 and December 2012. To control the imbalance, a 1:2 match was performed using propensity score matching (PSM) method based on patient’s heterogeneity and regimens of concurrent chemotherapy (CCT). The long-term treatment outcomes and toxicity between NCT group (n=67) and concurrent chemoradiotherapy (CRT) group (n=134) after PSM were compared. RESULTS: The 5-year overall survival (OS), progression-free survival (PFS), recurrence-free survival (RFS), local recurrence-free survival (LRFS), regional recurrence-free survival (RRFS) and distant failure-free survival (DFFS) were 78.8%, 69.1%, 90.0%, 90.0%, 100% and 78.3% for NCT group, while 79.5%, 75.7%, 92.7%, 94.2%, 96.1% and 82.7% for CRT group (P=0.305, 0.448, 0.790, 0.512, 0.104 and 0.671). It indicated that the treatment method (NCT+CCRT vs CCRT) was not the independent prognostic factor for the survival in NPC patients, and only patients who had completed at least two cycles of CCT got better OS, RFS and DFFS (P=0.009, 0.016 and 0.043), whether to receive NCT or not. No difference in the incidences of any acute and most late toxicity between the two groups was shown. CONCLUSION: Our study did not show the exact advantage of NCT followed by CCRT compared with CCRT alone or higher incidences of toxicity in NCT group. It suggests that NCT might not be necessary if two or more cycles of CCT are finished well in the era of IMRT, and when NCT is finished well, less than two cycles of CCT with IMRT could be enough. However, in the era of IMRT, the role of NCT still needs to be further explored. |
format | Online Article Text |
id | pubmed-5476787 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-54767872017-06-26 Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method Chen, Xueling Zhu, Xiaodong Liang, Zhongguo Li, Ling Qu, Song Chen, Kaihua Pan, Xinbin Onco Targets Ther Original Research PURPOSE: Whether neoadjuvant chemotherapy (NCT) followed by concurrent chemoradiotherapy (CCRT) could improve survival in nasopharyngeal carcinoma (NPC) remains controversial especially in the era of intensity-modulated radiation therapy (IMRT), and we explored the role of NCT for NPC patients. PATIENTS AND METHODS: A retrospective review was conducted of 255 NPC patients treated with NCT+CCRT (n=67) or CCRT alone (n=188) based on IMRT between December 2006 and December 2012. To control the imbalance, a 1:2 match was performed using propensity score matching (PSM) method based on patient’s heterogeneity and regimens of concurrent chemotherapy (CCT). The long-term treatment outcomes and toxicity between NCT group (n=67) and concurrent chemoradiotherapy (CRT) group (n=134) after PSM were compared. RESULTS: The 5-year overall survival (OS), progression-free survival (PFS), recurrence-free survival (RFS), local recurrence-free survival (LRFS), regional recurrence-free survival (RRFS) and distant failure-free survival (DFFS) were 78.8%, 69.1%, 90.0%, 90.0%, 100% and 78.3% for NCT group, while 79.5%, 75.7%, 92.7%, 94.2%, 96.1% and 82.7% for CRT group (P=0.305, 0.448, 0.790, 0.512, 0.104 and 0.671). It indicated that the treatment method (NCT+CCRT vs CCRT) was not the independent prognostic factor for the survival in NPC patients, and only patients who had completed at least two cycles of CCT got better OS, RFS and DFFS (P=0.009, 0.016 and 0.043), whether to receive NCT or not. No difference in the incidences of any acute and most late toxicity between the two groups was shown. CONCLUSION: Our study did not show the exact advantage of NCT followed by CCRT compared with CCRT alone or higher incidences of toxicity in NCT group. It suggests that NCT might not be necessary if two or more cycles of CCT are finished well in the era of IMRT, and when NCT is finished well, less than two cycles of CCT with IMRT could be enough. However, in the era of IMRT, the role of NCT still needs to be further explored. Dove Medical Press 2017-06-09 /pmc/articles/PMC5476787/ /pubmed/28652773 http://dx.doi.org/10.2147/OTT.S135590 Text en © 2017 Chen et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Chen, Xueling Zhu, Xiaodong Liang, Zhongguo Li, Ling Qu, Song Chen, Kaihua Pan, Xinbin Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method |
title | Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method |
title_full | Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method |
title_fullStr | Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method |
title_full_unstemmed | Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method |
title_short | Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method |
title_sort | long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (ccrt) vs ccrt alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476787/ https://www.ncbi.nlm.nih.gov/pubmed/28652773 http://dx.doi.org/10.2147/OTT.S135590 |
work_keys_str_mv | AT chenxueling longtermoutcomesofneoadjuvantchemotherapyfollowedbyconcurrentchemoradiotherapyccrtvsccrtalonefornasopharyngealcarcinomaintheeraofintensitymodulatedradiationtherapyusingpropensityscorematchingmethod AT zhuxiaodong longtermoutcomesofneoadjuvantchemotherapyfollowedbyconcurrentchemoradiotherapyccrtvsccrtalonefornasopharyngealcarcinomaintheeraofintensitymodulatedradiationtherapyusingpropensityscorematchingmethod AT liangzhongguo longtermoutcomesofneoadjuvantchemotherapyfollowedbyconcurrentchemoradiotherapyccrtvsccrtalonefornasopharyngealcarcinomaintheeraofintensitymodulatedradiationtherapyusingpropensityscorematchingmethod AT liling longtermoutcomesofneoadjuvantchemotherapyfollowedbyconcurrentchemoradiotherapyccrtvsccrtalonefornasopharyngealcarcinomaintheeraofintensitymodulatedradiationtherapyusingpropensityscorematchingmethod AT qusong longtermoutcomesofneoadjuvantchemotherapyfollowedbyconcurrentchemoradiotherapyccrtvsccrtalonefornasopharyngealcarcinomaintheeraofintensitymodulatedradiationtherapyusingpropensityscorematchingmethod AT chenkaihua longtermoutcomesofneoadjuvantchemotherapyfollowedbyconcurrentchemoradiotherapyccrtvsccrtalonefornasopharyngealcarcinomaintheeraofintensitymodulatedradiationtherapyusingpropensityscorematchingmethod AT panxinbin longtermoutcomesofneoadjuvantchemotherapyfollowedbyconcurrentchemoradiotherapyccrtvsccrtalonefornasopharyngealcarcinomaintheeraofintensitymodulatedradiationtherapyusingpropensityscorematchingmethod |